Zepbound Weight Loss Comparison - Search News

News

Zepbound beats Wegovy for weight loss

The Associated Press - Busines… · 8m

CEO of Novo Nordisk, maker of weight loss drug Wegovy, to step down

Pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, says its CEO is stepping down.

Big News Network · 1d

Zepbound beats Wegovy for weight loss in trial of blockbuster drugs

Eli Lilly’s obesity drug Zepbound led to nearly 50 percent more weight loss than Novo Nordisk’s Wegovy in the first direct comparison of the two blockbuster medications

Technology Networks · 16h

Zepbound Outcompetes Wegovy for Weight Loss in Head-to-Head Trials

Tirzepatide promoted greater weight loss in individuals with obesity than semaglutide in a clinical trial that compared the safety and efficacy of the injectable drugs. Learn more about the results of the SURMOUNT-5 Phase 3b trial.

1hon MSN

Popular injected weight loss medications work better for one sex. Researchers want to know why

In study after study, injected GLP-1 weight loss medications appear to work better on average for women than they do for men.

Dual-target weight-loss drug is 47% more effective than its rival

The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published ...

Why Mounjaro Tops Ozempic for Weight Loss

In the first head-to-head trial of its kind, people with obesity who took tirzepatide (sold under the brand names Mounjaro ...

MedPage Today on MSN3d

Zepbound and Wegovy Go Head to Head for Obesity: And the Winner Is ...

Tirzepatide (Zepbound) came out on top against semaglutide (Wegovy) for treating obesity in the head-to-head SURMOUNT-5 trial ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results